Trials / Completed
CompletedNCT00543023
A Study of the Treatment of Postmenopausal Women With Osteoporosis
Comparison of Teriparatide and Calcitonin in the Treatment of Postmenopausal Women With Osteoporosis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 104 (actual)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- Female
- Age
- 55 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
To compare the effect of treatment with teriparatide with that of salmon calcitonin in postmenopausal women with osteoporosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | teriparatide 20 micrograms/day subcutaneous | |
| DRUG | salmon calcitonin 100 IU/day subcutaneous |
Timeline
- Start date
- 2003-06-01
- Completion
- 2004-08-01
- First posted
- 2007-10-12
- Last updated
- 2007-10-12
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT00543023. Inclusion in this directory is not an endorsement.